Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis | NobleBlocks

Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis

Public

Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis

N

Shared by NobleBlocks on Jan 19, 2017 • 12:00 AM UTC

Authors:

S. Hauser

,

A. Bar-Or

,

G. Comi

Subject

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Jan 19, 2017 • 12:00 AM UTC

DOI:10.1056/NEJMoa1601277

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast